Profile of acotiamide in the treatment of functional dyspepsia

Masahiro Ueda, Eisuke Iwasaki, Hidekazu Suzuki

研究成果: Review article査読

14 被引用数 (Scopus)

抄録

Efficacy of acotiamide for improving symptoms in patients with functional dyspepsia was shown by several clinical trials. In a randomized, double-blind, placebo-controlled, parallel-group comparative Phase III trial conducted in Japan, 100 mg of acotiamide three times a day for 4 weeks was more effective than a placebo for improving symptoms, and quality of life. Acotiamide was well-tolerated treatment, with no significant adverse events. The aim of this review was to summarize the current evidence of the efficacy of acotiamide in the treatment of patients with functional dyspepsia.

本文言語English
ページ(範囲)83-88
ページ数6
ジャーナルClinical and Experimental Gastroenterology
9
DOI
出版ステータスPublished - 2016 4 6

ASJC Scopus subject areas

  • 消化器病学

フィンガープリント

「Profile of acotiamide in the treatment of functional dyspepsia」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル